BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/26/2021 7:48:01 AM | Browse: 1093 | Download: 2163
Publication Name World Journal of Stem Cells
Manuscript ID 65072
Country Italy
ISSN 1948-0210 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Research & Experimental Medicine
Manuscript Type Minireviews
Article Title Potential therapeutic applications of mesenchymal stem cells for the treatment of eye diseases
Manuscript Source Invited Manuscript
All Author List Giuliana Mannino, Cristina Russo, Anna Longo, Carmelina Daniela Anfuso, Gabriella Lupo, Debora Lo Furno, Rosario Giuffrida and Giovanni Giurdanella
ORCID
Author(s) ORCID Number
Giuliana Mannino http://orcid.org/0000-0002-9777-4154
Cristina Russo http://orcid.org/0000-0002-6709-4537
Anna Longo http://orcid.org/0000-0003-4696-6567
Carmelina Daniela Anfuso http://orcid.org/0000-0001-7951-1812
Gabriella Lupo http://orcid.org/0000-0002-9291-6969
Debora Lo Furno http://orcid.org/0000-0002-1971-8990
Rosario Giuffrida http://orcid.org/0000-0001-7494-3675
Giovanni Giurdanella http://orcid.org/0000-0002-4855-8615
Funding Agency and Grant Number
Corresponding Author Debora Lo Furno, PhD, Assistant Professor, Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, Universita' Square 2, Catania 95123, Italy. lofurno@unict.it
Key Words Mesenchymal stem cells; Eye diseases; Diabetic retinopathy; Glaucoma; Retinitis pigmentosa; Regenerative medicine
Core Tip Stem cell-based treatments have been extensively explored in the last few decades to develop therapeutic strategies. Mesenchymal stem cells (MSCs) offer several advantages, such as the absence of ethical concerns, easy harvesting, low immunogenicity and reduced tumorigenesis risks. MSC-based therapeutic approaches have been designed for the treatment of various ocular diseases, such as diabetic retinopathy, glaucoma and retinitis pigmentosa. In a large number of investigations, positive results have been obtained by in vitro experiments and in animal models. Many clinical trials have already been carried out and, although some adverse effects have been described, promising outcomes are reported.
Publish Date 2021-06-26 07:48
Citation Mannino G, Russo C, Longo A, Anfuso CD, Lupo G, Lo Furno D, Giuffrida R, Giurdanella G. Potential therapeutic applications of mesenchymal stem cells for the treatment of eye diseases. World J Stem Cells 2021; 13(6): 632-644
URL https://www.wjgnet.com/1948-0210/full/v13/i6/632.htm
DOI https://dx.doi.org/10.4252/wjsc.v13.i6.632
Full Article (PDF) WJSC-13-632.pdf
Full Article (Word) WJSC-13-632.docx